Global firms express interest to invest in Tanzania’s pharmaceutical industries

DAR ES SALAAM: TANZANIA is drawing increased investment into pharmaceutical manufacturing, driven by strong market demand, improved business conditions, and the development of dedicated industrial zones such as the Mloganzila pharmaceutical park.

Deputy Permanent Secretary in the Ministry of Health (Drugs and Medical Supplies), Emmanuel Tayari, made the statement today, June 1, 2026 in Dar es Salaam stating that the government is receiving growing interest from large international firms, including a Shanghai Stock Exchange–listed Chinese company planning to invest in the production of generic medicines.

He said investor confidence is being boosted by available infrastructure, regional market access through the EAC and SADC, and government facilitation mechanisms supporting the sector.

ALSO READ: Kikwete orders public servants to undergo induction training after reporting to their stations

“Several investors have already begun implementation phases at Mloganzila, with support from the Pharmaceutical Investment Acceleration Task Force, which is easing entry procedures and improving coordination,” he said.

Additionally, the PS said that Tanzania’s large domestic demand, combined with regional export opportunities, continues to position the country as a competitive hub for pharmaceutical production.

“The government remains committed to strengthening the sector to improve access to quality medicines and enhance healthcare delivery nationwide,” he said.